非酒精性脂肪肝
机制(生物学)
疾病
转录因子
慢性肝病
脂肪肝
生物信息学
氧化应激
KEAP1型
医学
发病机制
生物
内科学
生物化学
基因
肝硬化
哲学
认识论
作者
Wenfei Yu,Fengxia Zhang,Decheng Meng,Xin Zhang,Yanan Feng,Guoliang Yin,Pengpeng Liang,Suwen Chen,Hongshuai Liu
标识
DOI:10.2174/0115672018260113231023064614
摘要
Abstract: With the acceleration of people's pace of life, non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in the world, which greatly threatens people's health and safety. Therefore, there is still an urgent need for higher-quality research and treatment in this area. Nuclear factor Red-2-related factor 2 (Nrf2), as a key transcription factor in the regulation of oxidative stress, plays an important role in inducing the body's antioxidant response. Although there are no approved drugs targeting Nrf2 to treat NAFLD so far, it is still of great significance to target Nrf2 to alleviate NAFLD. In recent years, studies have reported that many natural products treat NAFLD by acting on Nrf2 or Nrf2 pathways. This article reviews the role of Nrf2 in the pathogenesis of NAFLD and summarizes the currently reported natural products targeting Nrf2 or Nrf2 pathway for the treatment of NAFLD, which provides new ideas for the development of new NAFLD-related drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI